Swedbank AB Decreases Stock Holdings in Itron, Inc. $ITRI

Swedbank AB lowered its stake in shares of Itron, Inc. (NASDAQ:ITRI) by 38.4% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,500 shares of the scientific and technical instruments company’s stock after selling 2,800 shares during the period. Swedbank AB’s holdings in Itron were worth $471,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Janney Montgomery Scott LLC boosted its holdings in Itron by 0.7% during the first quarter. Janney Montgomery Scott LLC now owns 16,795 shares of the scientific and technical instruments company’s stock worth $1,759,000 after buying an additional 121 shares in the last quarter. Evergreen Capital Management LLC lifted its holdings in shares of Itron by 3.7% in the first quarter. Evergreen Capital Management LLC now owns 3,586 shares of the scientific and technical instruments company’s stock valued at $376,000 after purchasing an additional 127 shares in the last quarter. Captrust Financial Advisors lifted its holdings in shares of Itron by 6.3% in the fourth quarter. Captrust Financial Advisors now owns 2,144 shares of the scientific and technical instruments company’s stock valued at $233,000 after purchasing an additional 128 shares in the last quarter. HighTower Advisors LLC lifted its holdings in shares of Itron by 2.0% in the first quarter. HighTower Advisors LLC now owns 7,501 shares of the scientific and technical instruments company’s stock valued at $786,000 after purchasing an additional 146 shares in the last quarter. Finally, Pinnacle Wealth Management Advisory Group LLC lifted its holdings in shares of Itron by 7.3% in the first quarter. Pinnacle Wealth Management Advisory Group LLC now owns 2,345 shares of the scientific and technical instruments company’s stock valued at $246,000 after purchasing an additional 160 shares in the last quarter. Hedge funds and other institutional investors own 96.19% of the company’s stock.

Insider Activity

In other news, SVP Christopher E. Ware sold 351 shares of the stock in a transaction on Monday, August 25th. The shares were sold at an average price of $125.31, for a total value of $43,983.81. Following the completion of the sale, the senior vice president owned 19,117 shares of the company’s stock, valued at $2,395,551.27. This represents a 1.80% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Joan S. Hooper sold 970 shares of the stock in a transaction on Monday, August 25th. The stock was sold at an average price of $125.31, for a total transaction of $121,550.70. Following the completion of the sale, the chief financial officer directly owned 88,394 shares of the company’s stock, valued at $11,076,652.14. The trade was a 1.09% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 3,037 shares of company stock valued at $380,566 in the last ninety days. 1.51% of the stock is owned by company insiders.

Analysts Set New Price Targets

ITRI has been the topic of several recent research reports. Johnson Rice downgraded shares of Itron from a “buy” rating to an “accumulate” rating in a report on Friday, August 1st. Stephens set a $130.00 price target on shares of Itron in a report on Monday, August 4th. Wall Street Zen raised shares of Itron from a “hold” rating to a “buy” rating in a report on Saturday, August 2nd. Guggenheim reaffirmed a “buy” rating and issued a $155.00 price target (up previously from $133.00) on shares of Itron in a report on Monday, July 14th. Finally, JPMorgan Chase & Co. raised shares of Itron from a “neutral” rating to an “overweight” rating and upped their price target for the company from $128.00 to $145.00 in a report on Thursday, July 31st. Ten research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $136.55.

Itron Stock Performance

Shares of ITRI stock opened at $117.47 on Wednesday. Itron, Inc. has a one year low of $90.11 and a one year high of $140.04. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.75 and a current ratio of 2.04. The company has a 50 day moving average price of $127.28 and a 200 day moving average price of $117.62. The firm has a market capitalization of $5.37 billion, a price-to-earnings ratio of 20.08, a price-to-earnings-growth ratio of 0.66 and a beta of 1.46.

Itron (NASDAQ:ITRI) last issued its quarterly earnings results on Thursday, July 31st. The scientific and technical instruments company reported $1.62 EPS for the quarter, topping the consensus estimate of $1.33 by $0.29. Itron had a net margin of 11.05% and a return on equity of 19.69%. The firm had revenue of $606.76 million during the quarter, compared to analyst estimates of $610.36 million. During the same quarter in the prior year, the business posted $1.21 earnings per share. Itron’s revenue for the quarter was down .4% compared to the same quarter last year. Itron has set its FY 2025 guidance at 6.000-6.200 EPS. Q3 2025 guidance at 1.450-1.550 EPS. Sell-side analysts anticipate that Itron, Inc. will post 5.33 EPS for the current year.

Itron Company Profile

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.